Key Findings
The North America region with regard to the metabolomics market is projected to record growth at a CAGR of 11.62% during the projected period. The increasing adoption of metabolomics across the medical sectors of the region is one of the most important drivers of market growth.

Market Insights
The metabolomics market in the North American region is studied through the market regions of Canada and the United States. The large presence of the major manufacturers in the metabolomics market of the region, have resulted in innovations in the domain of metabolomics. In the US region, metabolomics finds its applications in the study of metabolic processes and fundamental metabolic alterations in disease onset. The metabolomics also finds immense use in the pharmaceutical industry, where it is used as a tool to support improvements in patient care, which, in turn, drives the metabolomics market growth in the US. Further, the adoption of personalized medicine is increasing every year, and the wide-scale utilization of the metabolomics for personalized medicine is aiding the market growth. The United States is considered to be the largest biopharmaceutical market. The applications of metabolomics in the Canadian region is resulting in many biomarkers discoveries, thereby improving the screening methods. This factor helps the medical setting of the region, thereby augmenting the growth of the metabolomics market.

Competitive Insights
The well-established players in the market include, Shimadzu Corporation, Agilent Technologies, Inc., Apical Scientific Sdn Bhd, Human Metabolome Technologies, Inc., Metabolon Inc., Leco Corporation, Perkinelmer, Inc., Kore Technology Limited, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments